These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29171021)

  • 1. Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.
    Han J; Fei Y; Zhou F; Chen X; Zhang Y; Liu L; Fu J
    Br J Pharmacol; 2018 Feb; 175(3):544-557. PubMed ID: 29171021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenopus GLP-1-inspired discovery of novel GLP-1 receptor agonists as long-acting hypoglycemic and insulinotropic agents with significant therapeutic potential.
    Han J; Chen X; Wang Y; Fei Y; Zhou F; Zhang Y; Liu L; Si P; Fu J
    Biochem Pharmacol; 2017 Oct; 142():155-167. PubMed ID: 28668697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.
    Han C; Sun Y; Yang Q; Zhou F; Chen X; Wu L; Sun L; Han J
    Mol Pharm; 2021 Aug; 18(8):2906-2923. PubMed ID: 34240881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GLP-1/glucagon (GCG)/CCK
    Zhao S; Yan Z; Du Y; Li Z; Tang C; Jing L; Sun L; Yang Q; Tang X; Yuan Y; Han J; Jiang N
    Br J Pharmacol; 2022 Sep; 179(17):4360-4377. PubMed ID: 35484823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability.
    Han J; Sun L; Huang X; Li Z; Zhang C; Qian H; Huang W
    Br J Pharmacol; 2014 Dec; 171(23):5252-64. PubMed ID: 25039358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenopus GLP-1-based glycopeptides as dual glucagon-like peptide 1 receptor/glucagon receptor agonists with improved in vivo stability for treating diabetes and obesity.
    Li Q; Yang Q; Han J; Liu X; Fu J; Yin J
    Chin J Nat Med; 2022 Nov; 20(11):863-872. PubMed ID: 36427920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.
    Han J; Chen X; Zhao L; Fu J; Sun L; Zhang Y; Zhou F; Fei Y
    Mol Pharm; 2018 Jul; 15(7):2840-2856. PubMed ID: 29799205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.
    Han J; Huang Y; Chen X; Zhou F; Fei Y; Fu J
    Eur J Med Chem; 2018 Sep; 157():177-187. PubMed ID: 30096651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.
    Jiang N; Jing L; Li Q; Su S; Yang Q; Zhou F; Chen X; Han J; Tang C; Tang W
    Eur J Med Chem; 2021 Feb; 212():113118. PubMed ID: 33422984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Pharmaceutical Characterizations of Lipidated Dimeric Xenopus Glucagon-Like Peptide-1 Conjugates.
    Han J; Zhou F; Fei Y; Chen X; Fu J; Qian H
    Bioconjug Chem; 2018 Feb; 29(2):390-402. PubMed ID: 29239601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chronic administration of two novel long-acting
    Han J; Meng T; Chen X; Han Y; Fu J; Zhou F; Fei Y; Li C
    FASEB J; 2019 Jun; 33(6):7113-7125. PubMed ID: 30860869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon-like peptide 1 analogues with potent and long-acting hypoglycemic activity.
    Han J; Huang Y; Chen X; Zhou F; Fei Y; Fu J
    Eur J Pharm Sci; 2018 Oct; 123():111-123. PubMed ID: 30031858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.
    Han J; Fu J; Yang Q; Zhou F; Chen X; Li C; Yin J
    Eur J Med Chem; 2020 Jul; 198():112389. PubMed ID: 32388115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peptidic dual GLP-1/glucagon receptor agonist alleviates diabetes and diabetic complications in combination with low-intensity ultrasound.
    Ding WX; Wang HY; Peng LJ; Zhang F; Yuan S; Zhao LH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12423-12436. PubMed ID: 33336763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects.
    Zhong X; Chen Z; Chen Q; Zhao W; Chen Z
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30795583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering a potent and long-acting GLP-1/Y
    Xu J; Wang S; Wu H; Chen D; Han J; Lin Q
    Peptides; 2023 Nov; 169():171073. PubMed ID: 37536423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid selection of a novel GLP-1/GIP dual receptor agonist with prolonged glycemic control and weight loss in rodent animals.
    Wu Y; Ji T; Lv J; Wang Z
    Life Sci; 2020 Sep; 257():118025. PubMed ID: 32598933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stapled and
    Chen X; Fu J; Zhou F; Yang Q; Wang J; Feng H; Jiang W; Jin L; Tang X; Jiang N; Yin J; Han J
    J Med Chem; 2020 Nov; 63(21):12595-12613. PubMed ID: 33125843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents.
    Han J; Wang Y; Meng Q; Li G; Huang F; Wu S; Fei Y; Zhou F; Fu J
    Eur J Med Chem; 2017 May; 132():81-89. PubMed ID: 28342399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mono-PEGylated dimeric GLP-1 conjugate with enhanced receptor activation and prolonged anti-diabetes efficacies.
    Li P; Zhang J; Jia Y; Zhang Y
    Life Sci; 2020 Aug; 254():117752. PubMed ID: 32387412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.